Luis Gonçalves Sobrinho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Luis Gonçalves Sobrinho has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
M.A Santos
Department of Endocrinology, Portuguese Cancer Institute, 1099-023 Lisbon, Portugal
2 shared publications- Branca Maria Cavaco
Unidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG) 1
1 shared publication E Arranhado
Department of Endocrinology and Molecular Biology Laboratory, Portuguese Institute of Oncology, Lisbon
1 shared publicationH. Gil Ferreira
Department of Chemistry, Faculty of Science and Technology, New University of Lisbon, Lisbon, Portugal
1 shared publication- João Filipe Raposo
Portuguese Diabetes Association (APDP) Lisboa Portugal
1 shared publication K Uvnäs-Moberg
Serviço de Endocrinologia, Instituto Português de Oncologia, 1093 Lisboa Codex, Portugal
1 shared publication
Latest Publications
- 2 June 2003
- Published by Wiley in Clinical Endocrinology
- Vol. 58 (6) , 686-690
A practical method for the detection of macroprolactinaemia using ultrafiltration
Objective The aim of this study was to evaluate a method for the estimation of the percentage of big‐big prolactin (bb‐PRL) in serum, based on centrifugal ultrafiltration (UF) and to be used for the detection of macroprolactinaemia. design Serum samples were submitted to gel filtration chromatography (GFC), UF and precipitation with polyethylene glycol (PEG). patients Serum samples obtained from 13 patients with macroprolactinaemia (Group 1) and from 15 hyperprolactinaemic patients without macroprolactinaemia (Group 2) were studied by the three methods. measurements PRL was measured in serum, fractions from GFC, filtrate and retentate obtained after UF (this last measurement was used only to study the ‘recovery’ of PRL after UF and was not necessary for clinical purposes), and supernatant obtained after PEG precipitation. The calculation of the percentage of bb‐PRL, by UF, was made using a simple algorithm. results In Group 1 the percentages (mean and SD) of bb‐PRL as determined by GFC, UF and PEG were, respectively, 73 ± 16, 83 ± 5·3 and 78 ± 7·0. In Group 2, the percentages of bb‐PRL were, in the same order as above, 4·3 ± 8·2, 16 ± 19 and 3·7 ± 11. The difference of the means between Groups 1 and 2 was highly significant (P << 0·001) for all the three methods. In Group 1 the percentages of bb‐PRL were widely scattered when measured by GFC but closely clustered when measured by either UF or PEG. The opposite occurred in Group 2. conclusions The centrifugal ultrafiltration method for the detection of macroprolactinaemia is simple, inexpensive, requires only two prolactin assays and yields the same results as the polyethylene glycol precipitation method.
- 2 June 2003
- Published by Wiley in Clinical Endocrinology
- Vol. 58 (6) , 686-690
A practical method for the detection of macroprolactinaemia using ultrafiltration
Objective The aim of this study was to evaluate a method for the estimation of the percentage of big‐big prolactin (bb‐PRL) in serum, based on centrifugal ultrafiltration (UF) and to be used for the detection of macroprolactinaemia. design Serum samples were submitted to gel filtration chromatography (GFC), UF and precipitation with polyethylene glycol (PEG). patients Serum samples obtained from 13 patients with macroprolactinaemia (Group 1) and from 15 hyperprolactinaemic patients without macroprolactinaemia (Group 2) were studied by the three methods. measurements PRL was measured in serum, fractions from GFC, filtrate and retentate obtained after UF (this last measurement was used only to study the ‘recovery’ of PRL after UF and was not necessary for clinical purposes), and supernatant obtained after PEG precipitation. The calculation of the percentage of bb‐PRL, by UF, was made using a simple algorithm. results In Group 1 the percentages (mean and SD) of bb‐PRL as determined by GFC, UF and PEG were, respectively, 73 ± 16, 83 ± 5·3 and 78 ± 7·0. In Group 2, the percentages of bb‐PRL were, in the same order as above, 4·3 ± 8·2, 16 ± 19 and 3·7 ± 11. The difference of the means between Groups 1 and 2 was highly significant (P << 0·001) for all the three methods. In Group 1 the percentages of bb‐PRL were widely scattered when measured by GFC but closely clustered when measured by either UF or PEG. The opposite occurred in Group 2. conclusions The centrifugal ultrafiltration method for the detection of macroprolactinaemia is simple, inexpensive, requires only two prolactin assays and yields the same results as the polyethylene glycol precipitation method.
- 1 March 2003
- Published by Springer Nature in Pituitary
- Vol. 6 (1) , 35-39
Prolactin, Psychological Stress and Environment in Humans: Adaptation and Maladaptation
Non-puerperal lactation and/or hyperprolactinemia in humans have been related to psychological variables in a variety of ways: (1) Non-puerperal nursing; (2) Pseudopregnancy; (3) Rapid weight gain;...
- 1 March 2003
- Published by Springer Nature in Pituitary
- Vol. 6 (1) , 35-39
Prolactin, Psychological Stress and Environment in Humans: Adaptation and Maladaptation
Non-puerperal lactation and/or hyperprolactinemia in humans have been related to psychological variables in a variety of ways: (1) Non-puerperal nursing; (2) Pseudopregnancy; (3) Rapid weight gain;...
- 31 January 2003
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 28 (1) , 1-17
Cortisol, prolactin, growth hormone and neurovegetative responses to emotions elicited during an hypnoidal state
- 31 January 2003
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 28 (1) , 1-17
Cortisol, prolactin, growth hormone and neurovegetative responses to emotions elicited during an hypnoidal state
- 1 November 1998
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 23 (8) , 1005-1013
RAPID WEIGHT GAIN, AT LEAST IN SOME WOMEN, IS AN EXPRESSION OF A NEUROENDOCRINE STATE CHARACTERIZED BY REDUCED HYPOTHALAMIC DOPAMINERGIC TONE
- 1 November 1998
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 23 (8) , 1005-1013
RAPID WEIGHT GAIN, AT LEAST IN SOME WOMEN, IS AN EXPRESSION OF A NEUROENDOCRINE STATE CHARACTERIZED BY REDUCED HYPOTHALAMIC DOPAMINERGIC TONE
- 1 June 1998
- Published by S. Karger AG in Psychotherapy and Psychosomatics
- Vol. 67 (3) , 133-139
Emotional Aspects of Hyperprolactinemia
Patients with hyperprolactinemia often present with emotional difficulties. These occasionally persist even after successful treatment. Insight into the roots of their diseased state makes a difference in the handling of all cases, but becomes crucial in the not-so-rare situations in which the normalization of hormonal levels is not followed by a feeling of cure. This chapter attempts to provide details, discuss and situate in context the following blocks of pertinent information: (1) prolactin acts upon the central nervous system and variations in its concentrations do affect mood, emotions and behavior; (2) most actions of prolactin are directed to metabolical and behavioral adaptation to pregnancy and the care of the young; (3) even in the absence of pregnancy prolactin secretion responds to environmental stimuli under specific conditions. Whether adaptive, as in the case of surrogate maternity, or pathological, as in the case of pseudopregnancy, prolactin responds to a perceived need to take care of a child; (4) the facts that the clinical onset of prolactinomas often follows life-events and that these tumors occur preferentially in women brought up under specific conditions suggest the possibility that psychological factors may predispose to prolactinomas; (5) dealing with individual cases requires the perception that the relations between prolactin, emotions and feelings are circular, i.e., prolactin affects the brain and mood but, on the other hand, personality traits and environmental factors may stimulate the secretion of prolactin and may play a role in the genesis of the disease.
- 1 June 1998
- Published by S. Karger AG in Psychotherapy and Psychosomatics
- Vol. 67 (3) , 133-139
Emotional Aspects of Hyperprolactinemia
Patients with hyperprolactinemia often present with emotional difficulties. These occasionally persist even after successful treatment. Insight into the roots of their diseased state makes a difference in the handling of all cases, but becomes crucial in the not-so-rare situations in which the normalization of hormonal levels is not followed by a feeling of cure. This chapter attempts to provide details, discuss and situate in context the following blocks of pertinent information: (1) prolactin acts upon the central nervous system and variations in its concentrations do affect mood, emotions and behavior; (2) most actions of prolactin are directed to metabolical and behavioral adaptation to pregnancy and the care of the young; (3) even in the absence of pregnancy prolactin secretion responds to environmental stimuli under specific conditions. Whether adaptive, as in the case of surrogate maternity, or pathological, as in the case of pseudopregnancy, prolactin responds to a perceived need to take care of a child; (4) the facts that the clinical onset of prolactinomas often follows life-events and that these tumors occur preferentially in women brought up under specific conditions suggest the possibility that psychological factors may predispose to prolactinomas; (5) dealing with individual cases requires the perception that the relations between prolactin, emotions and feelings are circular, i.e., prolactin affects the brain and mood but, on the other hand, personality traits and environmental factors may stimulate the secretion of prolactin and may play a role in the genesis of the disease.
- 1 August 1995
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 80 (8) , 2342-2346
Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma.
The purpose of this study was to characterize the structure of big big PRL (bb-PRL) in patients with macroprolactinemia or prolactinomas. Serum samples from these patients were fractionated by Sephadex G-100 chromatography, and PRL was measured in the eluate by an immunoradiometric assay. The fractions containing bb-PRL were subjected to affinity chromatography with an antihuman immunoglobulin G (IgG) agarose column. PRL and IgG were assayed in the fractions obtained after affinity chromatography by immunoradiometric assay and radial immunodiffusion, respectively. bb-PRL was also immunoprecipitated with an antihuman PRL antibody, followed by polyacrylamide gel electrophoresis and Western blotting. We found that an average of 60% (range, 27-87%) of bb-PRL from patients with macroprolactinemia was retained by the agarose, indicating that this form of PRL contains an IgG. In one of the patients with prolactinoma, the big big form constituted 76% of the total PRL immunoreactivity. Most (75%) of the bb-PRL from this patient behaved as an IgG after affinity chromatography. In the two other patients with prolactinoma, we found that 22% and 25% of the bb-PRL, which represented only 2% and 3% of the total PRL in the serum, reacted as an IgG. In both groups of patients, the 23-kilodalton form of PRL was detected after the immunoprecipitation of bb-PRL. These results show that bb-PRL is in part a complex of 23-kilodalton PRL with an IgG and not an antibody mimicking the actions of PRL, as has been demonstrated for some large forms of growth-hormone.
- 1 August 1995
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 80 (8) , 2342-2346
Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma.
The purpose of this study was to characterize the structure of big big PRL (bb-PRL) in patients with macroprolactinemia or prolactinomas. Serum samples from these patients were fractionated by Sephadex G-100 chromatography, and PRL was measured in the eluate by an immunoradiometric assay. The fractions containing bb-PRL were subjected to affinity chromatography with an antihuman immunoglobulin G (IgG) agarose column. PRL and IgG were assayed in the fractions obtained after affinity chromatography by immunoradiometric assay and radial immunodiffusion, respectively. bb-PRL was also immunoprecipitated with an antihuman PRL antibody, followed by polyacrylamide gel electrophoresis and Western blotting. We found that an average of 60% (range, 27-87%) of bb-PRL from patients with macroprolactinemia was retained by the agarose, indicating that this form of PRL contains an IgG. In one of the patients with prolactinoma, the big big form constituted 76% of the total PRL immunoreactivity. Most (75%) of the bb-PRL from this patient behaved as an IgG after affinity chromatography. In the two other patients with prolactinoma, we found that 22% and 25% of the bb-PRL, which represented only 2% and 3% of the total PRL in the serum, reacted as an IgG. In both groups of patients, the 23-kilodalton form of PRL was detected after the immunoprecipitation of bb-PRL. These results show that bb-PRL is in part a complex of 23-kilodalton PRL with an IgG and not an antibody mimicking the actions of PRL, as has been demonstrated for some large forms of growth-hormone.